Advances in radiotherapy for head and neck cancer.

Radiotherapy and surgery are the principal curative modalities in treatment of head and neck cancer. Conventional (two dimensional, 2D and three-dimensional conformal radiotherapy, 3DCRT) result in significant side-effects and altered quality of life. Intensity modulated radiotherapy (IMRT) can spare the normal tissues, while delivering a curative dose to the tumour bearing tissues. Technical advances like volumetric intensity modulated arc therapy (VMAT) have helped optimise IMRT further. Image guided radiotherapy (IGRT) can be used to aid target delineation and also help reduce the PTV margins to further enhance the therapeutic ratio. Particle therapy using protons provides significant advantage in terms of normal tissue sparing and is recommended for small cranial tumours and in radiotherapy for paediatric patients.

[1]  Sadek Nehmeh,et al.  Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.

[2]  M. Hoogeman,et al.  Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration. , 2008, International journal of radiation oncology, biology, physics.

[3]  Suresh Senan,et al.  Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. , 2009, International journal of radiation oncology, biology, physics.

[4]  Barbara Vanderstraeten,et al.  Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[5]  E. Hammerlid,et al.  Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms , 2001, British Journal of Cancer.

[6]  V. Paleri,et al.  Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[7]  F. Feng,et al.  Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. , 2007, International journal of radiation oncology, biology, physics.

[8]  B. Maciejewski,et al.  Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  J. Sham,et al.  Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. , 2006, International journal of radiation oncology, biology, physics.

[10]  M. Martel,et al.  Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. , 1998, International journal of radiation oncology, biology, physics.

[11]  K. Harrington,et al.  Otological toxicity after postoperative radiotherapy for parotid tumours. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[12]  William M Mendenhall.  Mandibular osteoradionecrosis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  C. Gwede,et al.  Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  M. Yewondwossen,et al.  Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[15]  S Mutic,et al.  A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[16]  J. Deasy,et al.  A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. , 2001, International journal of radiation oncology, biology, physics.

[17]  A. Chan,et al.  Proton radiation therapy for head and neck cancer , 2008, Journal of surgical oncology.

[18]  D. Dearnaley,et al.  Results of intensity modulated radiotherapy (IMRT) in laryngeal and hypopharyngeal cancer: a dose escalation study , 2007 .

[19]  Ping Xia,et al.  Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.

[20]  Radhe Mohan,et al.  Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. , 2004, International journal of radiation oncology, biology, physics.

[21]  G. Laramore.  Role of particle radiotherapy in the management of head and neck cancer , 2009, Current opinion in oncology.

[22]  M. Bussière,et al.  Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  K. Harrington,et al.  First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  L. Weir,et al.  A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  S. Leung,et al.  Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  D. Dearnaley,et al.  A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  Luca Cozzi,et al.  Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.